Tetanus: all 206 studies
Page 2 of 3. Open to participants first (22), then studies with results posted, then the rest; newest registration first within each.
- A Study of Tetanus Antibody of Healthy AdultsCompletedNCT07724379
- Phase I Clinical Trial of Adsorbed Tetanus VaccineActive, not recruitingNCT07598890Phase 1
- A Study on the Immune Response and Safety of a Combined Vaccine Against Diphtheria, Tetanus and Acellular Pertussis (dTpa) in Japanese Healthy Pregnant WomenActive, not recruitingNCT07596199Phase 3
- Safety Monitoring of Boostagen® Vaccine in ThailandCompletedNCT07444502
- A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary SeriesActive, not recruitingNCT06947499Phase 2/3
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SNA02-48 Injection in Chinese Adult ParticipantsCompletedNCT06939777Phase 1/2
- Inter-lot Consistency Clinical Trial of Adsorbed Cell-free DTP (Three-component) Combined VaccineActive, not recruitingNCT06857370Phase 3
- Clinical Study on the Combined Administration of 15-Valent Pneumococcal Conjugate Vaccine and Diphtheria, Tetanus, Pertussis VaccineCompletedNCT06817187Phase 3
- A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component)CompletedNCT06708286Phase 2/3
- A Randomized, Open-Label, Parallel-Design Pharmacokinetic and Pharmacodynamic Interaction Study of TNM002 and Adsorbed Tetanus VaccineCompletedNCT06607380Phase 1
- Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of GR2001 in Chinese Healthy AdultsCompletedNCT06302374Phase 1/2
- A Study to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and OverCompletedNCT06123663Phase 1
- A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and OverCompletedNCT06120751Phase 3
- Prospective Biological Study to Evaluate the Persistence of COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in Follicular Lymphoma Patients Undergoing Frontline Induction Immuno-chemotherapy and Anti-CD20 MaintenanceActive, not recruitingNCT06070961
- A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above)CompletedNCT06056050Phase 1
- Safety and Immunogenicity of Tetanus Vaccine, Adsorbed in 18~44 Years Old PopulationCompletedNCT06049940Phase 3
- Real-time Artificial Intelligent (AI)-Assisted Muscle Ultrasound for Monitoring Muscle Mass Reduction in ICU PatientsCompletedNCT06034093Not applicable
- A Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed(DTcP)Active, not recruitingNCT05951725Phase 3
- The Effect of Helfer Skin Tap Technique During Tetanus Injection in Pregnant WomenCompletedNCT05761340Not applicable
- Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria.Active, not recruitingNCT05480462Phase 3
- Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary SeriesCompletedNCT05457946Phase 2/3
- Comparison of Train of Four, Tetanus 50 and 100 Hz Recovery After Rocuronium Block Reversed by NeostigmineCompletedNCT05224648Not applicable
- A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, AdsorbedActive, not recruitingNCT05091619Phase 3
- Comparison of Train of Four, Tetanus 50 and 100 Hz Recovery After Rocuronium Block Reversed by SugammadexCompletedNCT05003024Not applicable
- Evaluation of the Vaccination Coverage of Cirrhotic Patients Followed in the General Hospitals in France in 2021CompletedNCT04939350
- To Evaluate the Immunogenicity and Safety of 'BR-TD-1001' Administered Intramuscularly in Healthy ChildrenCompletedNCT04618939Phase 3
- To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 YearsStatus unknownNCT04618640Phase 3
- Multicenter Study of Tetanus Patients in Fujian Province of ChinaCompletedNCT04165928
- Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed .CompletedNCT04099303Phase 1
- Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy InfantsStatus unknownNCT04073459Phase 2
- A Phase IV Study to Assess the Safety of EupentaTM InjStatus unknownNCT04056728Phase 4
- A Study to Describe the Safety Profile and Compare the Immune Response of 4 Different Formulations of an Investigational Tdap Vaccine When Compared to Licensed Tdap Vaccine in Young Adults in CanadaCompletedNCT03958799Phase 1
- The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 WeeksCompletedNCT03931239Not applicable
- Study on the Response to Tetanus Vaccination of People Living With HIVCompletedNCT03853681Not applicable
- Immunogenicity and Safety of Bivalent Meningococcal Serogroups A and C Tetanus Toxoid Conjugate Vaccine in ChineseCompletedNCT03714737Phase 3
- Immunogenicity and Safety of a Tetanus-diphtheria Vaccine and a 13-valent Pneumococcal Conjugate VaccineCompletedNCT03552445Phase 4
- Antitetanus Vaccination for People Older Than 65 Years.CompletedNCT03266211
- Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, ColombiaTerminatedNCT03188458Phase 4
- Intrathecal Tetanus Immunoglobulin to Treat TetanusCompletedNCT02999815Phase 1/2
- Interest of a Tetanus Test at a Fixed Remifentanil Concentration Before Laryngoscopy and Skin IncisionCompletedNCT02884310Phase 4
- DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected InfantsCompletedNCT02817451Phase 3
- Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) VaccineStatus unknownNCT02813486Phase 1/2
- Safety and Efficacy of Two Tetanus-Diphtheria Vaccines for a Donor Hyper Immunization ProgramCompletedNCT02673255Phase 1
- Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia.CompletedNCT02569879
- Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruSCompletedNCT02458183Phase 3
- Duration of Protection: GSK DTaP VaccinesCompletedNCT02447978
- Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After BirthCompletedNCT02428491Phase 3
- DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese InfantsCompletedNCT02274285Phase 3
- Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 WeeksStatus unknownNCT02257645
- DTaP-IPV-Hep B-PRP~T Combined Vaccine Versus DTaP-IPV//PRP~T Combined Vaccine + Hep B Vaccine in Hep B Primed InfantsCompletedNCT02094833Phase 3
- Study of Tetanus and Diphtheria Toxoids Adsorbed Combined With Component Pertussis Vaccine and Inactivated PoliomyelitisCompletedNCT02040636Phase 2
- Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China.CompletedNCT01993173Phase 3
- Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa VaccinationCompletedNCT01983540Phase 3
- A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and UnijectCompletedNCT01917357Phase 3
- Post Authorisation Safety Study of Triaxis as a 5th Dose in 4-6 Year Old Spanish ChildrenCompletedNCT01583049
- Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in KoreaCompletedNCT01568060
- Comparative Study of Two Tetanus Toxoid Vaccination Strategies: Cold Chain Versus Controlled Temperature ChainCompletedNCT01559597Not applicable
- The Change of the Tetanus Antibody Titer After Single Injection of Td and Simultaneous Injection of TIG With TdCompletedNCT01338688
- Pneumonia in Tetanus StudyCompletedNCT01331252Not applicable
- Vaccination Against Pertussis, Tetanus and Diphtheria in Patients Suffering From Rheumatoid ArthritisStatus unknownNCT01301703Phase 4
- Safety and Immunogenicity Study of a Diphtheria, Tetanus, Acellular Pertussis and Poliomyelitis Vaccine (REPEVAX) Followed by 2 Doses of a Diphtheria, Tetanus and Poliomyelitis Vaccine (REVAXIS) in Subjects of 40 Years of Age or OlderCompletedNCT01287949Phase 3
- Comparison of GSK Biologicals' Reduced Antigen Diphtheria and Tetanus Toxoids and Acellular Pertussis- Inactivated Poliovirus Vaccine, to BoostrixTM and Inactivated Poliovirus Vaccine Administered Separately and With Revaxis®CompletedNCT01277705Phase 3
- Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy AdultsCompletedNCT01267058Phase 3
- Study of Reduced-antigen-content Acellular Pertussis Vaccine and Diphtheria-Tetanus-Acellular Pertussis VaccineCompletedNCT01262924Phase 3
- Safety and Immunogenicity Study of Concomitant Versus Non Concomitant Administration of a Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccine (REPEVAX) and Influenza Vaccine (VAXIGRIP) in Subjects Aged From 60 Years OldCompletedNCT01249183Phase 3
- Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants.CompletedNCT01214889Phase 3
- Antibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control VaccineCompletedNCT01105559
- A Study of DTaP//PRP-T Combined Vaccine (ACTACEL) Versus Local DTaP and Act-HIB Monovalent Vaccine in Healthy InfantsCompletedNCT01062477Phase 3
- Study in Infants (6-12 Months) Comparing Two Doses of a Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Vaccine Versus a Tetanus Toxoid-Conjugated Vaccine Available for the Prevention of Haemophilus Influenzae Type b Infections in ChinaCompletedNCT01044316Phase 3
- Immunogenicity and Safety of Tetanus, Diphtheria and Mono Component Acellular Pertussis (TdaP) Vaccine in Comparison to Tetanus and Diphtheria (Td) Vaccine When Given as Booster Vaccinations to AdultsCompletedNCT01033877Phase 3
- Immunogenicity and Safety of TETRAXIM™ Given as a Booster Dose at 4 to 6 Years of AgeCompletedNCT01031303Phase 4
- Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable DiseaseStatus unknownNCT00932269
- Study Comparing a Tdap-IPV Combined Vaccine With a Tetanus Monovalent Vaccine in Healthy AdultsCompletedNCT00928785Phase 3
- Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination VaccineStatus unknownNCT00877357Phase 4
- An Immunogenicity and Safety Study of Tetanus, Diphtheria and Acellular Pertussis Vaccine BoosterStatus unknownNCT00870350Phase 4
- Surveillance Program to Determine Product Specific Rates of Invasive Hib DiseaseCompletedNCT00855855
- Database Surveillance Safety Study of PENTACEL® VaccineCompletedNCT00804284
- Pertussis Vaccine in Healthy Pregnant WomenCompletedNCT00707148Phase 1
- Effect of Levamisole Supplementation on Tetanus Vaccination Response Rates in Hemodialysis PatientsCompletedNCT00705692Phase 2
- Phase IV Interchangeability Study of a Liquid Pentavalent Combination VaccineCompletedNCT00674908Phase 4
- Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended VaccineCompletedNCT00662870Phase 3
- Safety and Immunogenicity Study of a Liquid Pentavalent Combination VaccineCompletedNCT00617812Phase 4
- Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines.TerminatedNCT00544271Phase 4
- Immunogenicity and Safety Study of a Booster Dose (5th) of Diphteria-Tetanus-Pertussis-Polio VaccineCompletedNCT00514059Phase 4
- Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 MonthsCompletedNCT00453570Phase 3
- REVAXIS® Versus DT Polio® as a Second Booster in 6 Year-old ChildrenCompletedNCT00447525Phase 3
- Tetanus Immunization in Subjects With No Immunization History or With Tetanus Antibody Levels Below Protective LevelsTerminatedNCT00437671Phase 4
- Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of AgeCompletedNCT00376779Phase 2
- Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar®CompletedNCT00362427Phase 2
- Study to Compare Pediacel® to Infanrix®-IPV+Hib When Both Are Co-Administered With Prevenar® in Infants and ToddlersCompletedNCT00343421Phase 3
- Immunogenicity and Safety of Tetraxim Versus Local DTP + IPVCompletedNCT00319852Phase 3
- Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination SchedulesCompletedNCT00316147Phase 3
- Post-marketing Safety Study of GSK Biologicals' Boostrix® VaccineCompletedNCT00297856
- Comparison of Safety and Immunogenicity of Pediacel™ and Infanrix™ IPV+Hib (Penta) Given in a 3 Dose Schedule in InfantsCompletedNCT00287092Phase 3
- Immunogenicity and Safety of Pentaxim™ in an Indian PopulationCompletedNCT00259337Phase 3
- Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in ThailandCompletedNCT00255021Phase 4
- Immunogenicity and Safety of Pentaxim in South African InfantsCompletedNCT00254969Phase 3
- Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in InfantsCompletedNCT00197275Phase 3
- Immunology of Non-specific Effects of VaccineCompletedNCT00168545Phase 4
- Pentavalent DTaP-Hep B-IPVCompletedNCT00133445Phase 2